Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
AstraZeneca
Nurix Therapeutics, Inc.
Merck Sharp & Dohme LLC
First Affiliated Hospital of Zhejiang University
Toray Industries, Inc
National Institutes of Health Clinical Center (CC)
Jazz Pharmaceuticals
National University Hospital, Singapore
Seoul National University Bundang Hospital
Instituto do Cancer do Estado de São Paulo
AbbVie
City of Hope Medical Center
Uppsala University
National Cancer Institute (NCI)